Drreddys Laboratories | RDY - Zysk Brutto Na Sprzedaży





Zysk Brutto Na Sprzedaży Zmiana Data
ANI Pharmaceuticals USD 124.18M 12.39M 2025-12
Aurora Cannabis CAD 46.62M 14.33M 2025-12
Bayer EUR 6.94B 1.58B 2025-12
Canopy Growth CAD 21.47M 434K 2025-12
Cipla INR 41.64B 6.31B 2025-12
Corcept Therapeutics USD 162.02M 37.56M 2026-03
Drreddys Laboratories INR 46.81B 10.24B 2025-12
GlaxoSmithKline GBP 5.75B 429M 2026-03
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Lonza CHF 1.29B 248M 2025-06
Novartis USD 10.07B 184M 2026-03
Pacira USD 126.64M 15.61M 2026-03
Phibro Animal Health USD 133.5M 12.6M 2025-12
Prestige Brands USD 157.37M 5.79M 2025-12
Richter Gedeon HUF 143.37B 25.78B 2025-09
Sun Pharmaceuticals INR 107.66B 2.05B 2025-09
Supernus Pharmaceuticals USD 129.36M 34.68M 2026-03
Teva Pharmaceutical Industries USD 2.11B 547M 2026-03